Word

BDC

Status

Pending

Status Code

630

Status Date

Thursday, April 4, 2024

Serial Number

79392996

Mark Type

4

Filing Date

Tuesday, December 19, 2023

Trademark Owner History

Bicycletx Limited

Classifications

5 Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceutical products and preparations for use in relation to oncology; pharmaceutical products and preparations for use in relation to ophthalmology; pharmaceutical products and preparations for use in relation to neurology; anti-infective pharmaceutical products and preparations; pharmaceutical products and preparations for the treatment and/or prevention of respiratory disease; pharmaceutical products and preparations for the treatment and/or prevention of cardiovascular disease; pharmaceutical products and preparations for the treatment and/or prevention of metabolic disease; pharmaceutical products and preparations for the treatment and/or prevention of viral infections; pharmaceutical products and preparations for use in diagnostics and imaging; pharmaceutical products and preparations for the treatment and/or prevention of renal disease; pharmaceutical products and preparations for the treatment and/or prevention of gastrointestinal disease; pharmaceutical products and preparations for the treatment and/or prevention of muscular skeletal disease

42 Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical research and development services; medical research and development services; pharmaceutical testing and clinical trials; clinical trials; research and development in the field of oncology; research and development in the field of ophthalmology; research and development in the field of neurology; research and development in the field of anti-infective pharmaceuticals; research and development in the field of respiratory disease; research and development in the field of cardiovascular disease; research and development in the field of metabolic disease; research and development in the field of antiviral drugs; research and development in the field of diagnostics and imaging; research and development in the field of renal disease; research and development in the field of gastrointestinal disease; research and development in the field of muscular skeletal disease; information consultancy and advisory services relating to the aforesaid

Trademark Events

Apr 4, 2024

Sn Assigned For Sect 66a Appl From Ib

Apr 12, 2024

New Application Office Supplied Data Entered